产品名称 Bortezomib - PS 341
产品货号 Axon 1810 CAS [179324-69-7] MF C19H25BN4O4MW 384.24 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Highly selective and reversible inhibitor of the 26S proteasome; a chemotherapy agent used in the treatment of multiple myeloma; shown to have anti-tumor activity in B cell malignancies References Certificates Categories Extra info P Bonvini et al. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia 2007, 21(4), 838–842.   S Williams et al. Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts. Mol. Cancer Ther. 2003, 2, 835-843.   Y Ling et al. Mechanisms of Proteasome Inhibitor PS-341-induced G2-M-Phase Arrest and Apoptosis in Human Non-Small Cell Lung Cancer Cell Lines. Clin. Cancer Res. 2003, 9, 1145-1154.   A Corso et al. Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. Leukemia & Lymphoma 2010, 51(2), 236-242. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Proteasome 26S Ubiquitin EC 3.4 Inhibitor of 26S proteasome Chemical name (R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butan-2-ylboronic acid Parent CAS No. [179324-69-7] Order Size Unit Price Stock 5 mg €85.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情
产品资料